Patient knowledge and awareness on inflammatory bowel disease as it evolves as a global disease: a scoping review [0.03%]
作为全球性疾病的炎症性肠病患者知识和意识的现状：系统综述
Arshdeep Singh,Arshia Bhardwaj,Anuraag Jena et al.
Arshdeep Singh et al.
Background: Patient knowledge is pivotal to inflammatory bowel disease (IBD) management, yet educational opportunities vary widely worldwide. This scoping review maps existing evidence on patient knowledge, explores regio...
IOlBD evidence-based consensus on the use of artificial intelligence for assessment of endoscopic and histologic endpoints in clinical trials of inflammatory bowel disease [0.03%]
基于证据的共识：在炎症性肠病临床试验中使用人工智能评估内镜和组织学终点的应用
Axel Dignass,Neeraj Narula,Krishan Pratap et al.
Axel Dignass et al.
Background & aims: Central reading of endoscopy and histopathology is the current standard for disease activity assessment in inflammatory bowel disease (IBD) clinical trials but is limited by interreader and intrareader ...
Risk of intestinal cancer in Crohn's disease: re-analysis and meta-regression of population-based cohort studies [0.03%]
克罗恩病肠道癌症风险：基于人口队列研究的再分析与元回归分析
Enrico Altiero Giusto,Paolo Pinton,Carlotta Giorgi et al.
Enrico Altiero Giusto et al.
Background and aims: The risk of intestinal malignancy in Crohn's disease (CD) varies across regions. Given the rising global cancer prevalence, this study aimed to summarize evidence and evaluate associations between CD ...
TWEAK is increased in ulcerative colitis and contributes to fibroblast-mediated monocyte activation via heterologous non-canonical NF-kB/STAT3 signaling [0.03%]
溃疡性结肠炎中TWEAK升高并通过异源非经典NF-κB/STAT3信号通路促进成纤维细胞介导的单核细胞活化
Carlos Matellan,Bella Raphael,Gareth R Jones et al.
Carlos Matellan et al.
Background and aims: Interactions between fibroblasts and monocytes have emerged as a contributing factor in inflammatory bowel disease (IBD) pathogenesis and therapy resistance, owing to the ability of both cell types to...
Correction to: Susceptibility to inflammatory bowel diseases promotes invasive carcinomas in a murine model of ATF6-driven colon cancer [0.03%]
Correction to: 具有炎症性肠病易感性的小鼠模型促进了ATF6驱动的结肠癌侵袭性癌的发展
Published Erratum
Journal of Crohn's & colitis. 2026 Feb 5;20(2):jjaf226. DOI:10.1093/ecco-jcc/jjaf226 2026
REACH: C-cause [0.03%]
reach:C-原因
Stephanie Williams,Laween Meran,Sara McCartney et al.
Stephanie Williams et al.
Inflammatory bowel disease (IBD) arises from a multifaceted interplay of genetic predisposition, environmental triggers, microbial dynamics, and immune dysregulation. This complex network of interacting factors disrupts gut homeostasis, lea...
Hyder Said,Calum D Moulton,Ailsa Hart et al.
Hyder Said et al.
There is a growing body of evidence supporting the value of multidisciplinary teams in delivering comprehensive, holistic care for individuals with inflammatory bowel disease (IBD). Members of this team often include gastroenterologists, ps...
Olga Maria Nardone,Beatriz Gros,Tommaso Lorenzo Parigi et al.
Olga Maria Nardone et al.
The global burden of inflammatory bowel disease (IBD) is expanding into newly industrialized and lower- and lower-middle-income countries and is projected to place increasing pressure on healthcare systems. Advances in treat-to-target strat...
Amit Thakor,Saiumaeswar Yogakanthi,Nurulamin M Noor et al.
Amit Thakor et al.
Both Crohn's disease and ulcerative colitis are associated with heterogeneity of presentation, disease course, and outcomes between individuals. The frequency of flares and progression to complications can have a profound impact on quality ...
Equitable access to inflammatory bowel disease care: challenges, strategies, and future directions [0.03%]
炎症性肠病诊疗的公平可及：挑战、策略与未来方向
Johan Burisch,Rupa Banerjee,Gillian Watermeyer
Johan Burisch
The global burden of inflammatory bowel disease (IBD) is rising rapidly, not only in high-income countries but also in low- and middle-income countries (LMICs). At the same time, access to high-quality care remains uneven. Patients in LMICs...